Sunday, 13 September 2026

Indian corporate news, decoded into deal flow

NSE LIVE
NIFTY 50 INDIA VIX
as of
MARKETS
DEAL FLOW
eMudhra Named GLEIF Validation Agent, Expands… ▲ Market News / Economy Lenskart Raises Stake in Dimension NXG… ▲ Mergers & Acquisitions Horizon Industrial Parks Q1 FY27: ₹2,000… ▲ Capex & Future Plan SEBI Proposes Tighter Cybersecurity Rules for… ▲ Market News / Economy India’s Next Capex Supercycle: 10 Sectors… ▲ Capex & Future Plan Flipkart Minutes Grows 4X, Reaches 1,200… ▲ Market News / Economy Tata Sons Listing Back in Focus… ▲ Market News / Economy
Home / Capex & Future Plans / Sai Life Sciences Expands R&D Capabilities with New Hyderabad Facility
CX · Capex & Future Plans

Sai Life Sciences Expands R&D Capabilities with New Hyderabad Facility

Sai Life Sciences Expands R&D Capabilities with New Hyderabad Facility

Sai Life Sciences to Expand R&D Capabilities with New Facility in Hyderabad

Sai Life Sciences Limited has announced plans to enhance its R&D capabilities by establishing a new research and development facility in Shamirpet, Hyderabad.

Key Highlights of the Expansion

  • Location: The new facility will be situated in Shamirpet, Hyderabad, augmenting the existing Unit II Hyderabad facility.
  • Land Lease: The company has secured 1.21 acres of land, including existing building structures, through a long-term lease agreement.
  • Purpose: The facility aims to bolster the company’s R&D infrastructure, supporting future growth.
  • Investment: The project requires an initial investment of Rs. 15 crore, funded entirely through internal accruals.
  • Timeline: Partial operations are projected to commence in Q4 of FY 2025-26.

This expansion underscores Sai Life Sciences’ commitment to strengthening its research capabilities, paving the way for innovation and long-term growth.